These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16006592)

  • 21. Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting.
    Kim B; Lee SH; Choi TK; Suh S; Kim YW; Lee E; Yook KH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1231-5. PubMed ID: 18442879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosing issues and depot medication in the maintenance treatment of schizophrenia.
    Kane JM
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():65-71. PubMed ID: 8866767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.
    Buckley PE; Evans D
    Postgrad Med; 2006 Sep; Spec No():5-19. PubMed ID: 17128657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term considerations after switching antipsychotics.
    Weiden PJ; Aquila R; Emanuel M; Zygmunt A
    J Clin Psychiatry; 1998; 59 Suppl 19():36-49. PubMed ID: 9847051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects.
    Freudenreich O; McEvoy JP
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):115-21. PubMed ID: 23006236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia.
    Young AH
    J Clin Psychiatry; 2007; 68 Suppl 6():24-5. PubMed ID: 17650056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
    Motlová L; Spaniel F; Höschl C; Balon R
    Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New generation antipsychotic drugs and compliance behaviour.
    Voruganti LP; Baker LK; Awad AG
    Curr Opin Psychiatry; 2008 Mar; 21(2):133-9. PubMed ID: 18332660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
    Murawiec S
    Psychiatr Pol; 2005; 39(6):1185-98. PubMed ID: 16526184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing clinicians' management of first episode schizophrenia using clinical case vignettes.
    Huffman JC; Freudenreich O; Romeo S; Baer L; Sutton-Skinner K; Petersen T; Fromson JA; Birnbaum RJ
    Early Interv Psychiatry; 2010 Feb; 4(1):31-8. PubMed ID: 20199478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase-specific psychosocial interventions for first-episode schizophrenia.
    Miller R; Mason SE
    Bull Menninger Clin; 1999; 63(4):499-519. PubMed ID: 10589141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.